These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30348449)

  • 1. Therapeutic tolerance in autoimmune disease.
    Rayner F; Isaacs JD
    Semin Arthritis Rheum; 2018 Dec; 48(3):558-562. PubMed ID: 30348449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
    Stojanovic I; Dimitrijevic M; Vives-Pi M; Mansilla MJ; Pujol-Autonell I; Rodríguez-Fernandez S; Palova-Jelínkova L; Funda DP; Gruden-Movsesijan A; Sofronic-Milosavljevic L; Hilkens CMU; Martinez-Caceres E; Miljkovic D
    Curr Pharm Des; 2017; 23(18):2623-2643. PubMed ID: 28201972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides as therapeutic approach to autoimmune diseases.
    Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M
    Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.
    Chatenoud L
    Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory immune cells and functions in autoimmunity and transplantation immunology.
    Papp G; Boros P; Nakken B; Szodoray P; Zeher M
    Autoimmun Rev; 2017 May; 16(5):435-444. PubMed ID: 28286106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell immunomodulation--the Holy Grail of therapeutic tolerance.
    Isaacs JD
    Curr Opin Pharmacol; 2007 Aug; 7(4):418-25. PubMed ID: 17611158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases.
    Reijm S; Kissel T; Toes REM
    Eur J Immunol; 2020 Dec; 50(12):1885-1894. PubMed ID: 33152108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.
    Moorman CD; Sohn SJ; Phee H
    Front Immunol; 2021; 12():657768. PubMed ID: 33854514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerising cellular therapies: what is their promise for autoimmune disease?
    Mosanya CH; Isaacs JD
    Ann Rheum Dis; 2019 Mar; 78(3):297-310. PubMed ID: 30389690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    Calabrese LH; Caporali R; Blank CU; Kirk AD
    J Autoimmun; 2020 Dec; 115():102546. PubMed ID: 32980229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and immune system.
    Hussain M; Javeed A; Ashraf M; Zhao Y; Mukhtar MM; Rehman MU
    Int Immunopharmacol; 2012 Jan; 12(1):10-20. PubMed ID: 22172645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance and autoimmunity. Novel therapeutic approaches].
    Ciliberti E; Carambia L; Cavallin S; Cerda OL; Poderoso JJ; Rabinovich GA
    Medicina (B Aires); 2009; 69(4):460-5. PubMed ID: 19770103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerizing Strategies for the Treatment of Autoimmune Diseases: From
    Cauwels A; Tavernier J
    Front Immunol; 2020; 11():674. PubMed ID: 32477325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoints in lymphocyte development and autoimmune disease.
    von Boehmer H; Melchers F
    Nat Immunol; 2010 Jan; 11(1):14-20. PubMed ID: 20016505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-induced autoimmunity and immune hyperreactivity.
    Prud'homme GJ; Parfrey NA; Vanier LE
    Autoimmunity; 1991; 9(4):345-56. PubMed ID: 1954315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.